Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Lifecare AS ( (DE:LFC0) ) has provided an update.
Lifecare ASA has disclosed that Hannibal Invest AS, a company closely associated with board member and primary insider Hans Hekland, has sold 211,856 shares in the company at NOK 0.4456 per share. After the transaction, Hannibal Invest AS still retains 746,302 shares and 705,196 Series 2 warrants, indicating that Hekland-linked interests remain significantly exposed to the company despite the partial divestment.
The transaction, reported under securities trading and market abuse regulations, provides transparency on insider-related dealings that could influence investor sentiment toward Lifecare. While the sale modestly reduces insider ownership, the continued large holding of shares and warrants suggests ongoing alignment with the company’s long-term prospects in the medical sensor and continuous glucose monitoring market.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes. The company is concentrating on bringing next-generation Continuous Glucose Monitoring systems to market, using osmotic pressure as its core sensing principle for applications in both humans and pets.
Average Trading Volume: 3,951,568
Current Market Cap: NOK114.6M
For a thorough assessment of LFC0 stock, go to TipRanks’ Stock Analysis page.